Leucine kinetics during a brief fast in diabetes in pregnancy

Satish C. Kalhan, Scott Denne, Deepak M. Patel, Isaac F. Nuamah, Samuel M. Savin

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The effect of diabetes in pregnancy on leucine turnover and oxidation was examined in 12 insulin-dependent diabetic (IDDM) subjects and 12 gestationally diabetic (GDM) subjects during the third trimester of pregnancy. The data were compared with those in normal pregnant women studied during the same time period and reported previously. Eight of the IDDM subjects were on continuous subcutaneous insulin infusion (insulin pump), and four were on conventional twice-daily insulin treatment. Of the GDM group, seven were on insulin therapy and five were on dietary management. Leucine kinetics were quantified using [1-13C]leucine tracer in combination with respiratory calorimetry and measurement of lean body mass using the H2[18O] dilution method. In addition, glucose kinetics were measured in insulin-treated subjects using [6,62H2]glucose tracer. Despite rigorous metabolic control, fasting plasma glucose (IDDM 5.5 ± 1.9 mmol/L [P <.05], GDM 4.7 ± 1.3 [P <.01], controls 3.6 ± .6, mean ± SD) and hemoglobin A1 ([HbA1] IDDM 7.9 ± 1.9%, GDM 7.5% ± 2.1%) levels were higher in diabetic subjects. Although total insulin levels were higher in insulin-treated diabetic subjects, free-insulin concentrations were similar in all groups. Rates of excretion of urinary urea nitrogen and respiratory quotients were also similar. The rate of glucose turnover was lower in insulin-treated subjects compared with normals. Leucine flux, a measure of the rate of protein breakdown, and leucine oxidation were higher in IDDM and insulin-treated GDM subjects. The rate of leucine oxidation was increased in conventionally managed IDDM and insulin-treated GDM subjects. The increased rate of protein breakdown suggests an increased entry of amino acids into the metabolic pool, which in combination with the normal urea excretion rate, ie, the normal rate of amino acid/protein oxidation, may result in increased availability of amino acids for transplacental flux. Thus, rigorous management of IDDM in pregnancy and of insulin-treated GDM does not normalize whole-body protein breakdown, and may provide an explanation for the persistent fetal morbidity in diabetes in pregnancy.

Original languageEnglish (US)
Pages (from-to)378-384
Number of pages7
JournalMetabolism: Clinical and Experimental
Volume43
Issue number3
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Pregnancy in Diabetics
Leucine
Insulin
Type 1 Diabetes Mellitus
Glucose
Amino Acids
Urea
Proteins
Subcutaneous Infusions
Infusion Pumps
Calorimetry
Third Pregnancy Trimester

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Leucine kinetics during a brief fast in diabetes in pregnancy. / Kalhan, Satish C.; Denne, Scott; Patel, Deepak M.; Nuamah, Isaac F.; Savin, Samuel M.

In: Metabolism: Clinical and Experimental, Vol. 43, No. 3, 1994, p. 378-384.

Research output: Contribution to journalArticle

Kalhan, Satish C. ; Denne, Scott ; Patel, Deepak M. ; Nuamah, Isaac F. ; Savin, Samuel M. / Leucine kinetics during a brief fast in diabetes in pregnancy. In: Metabolism: Clinical and Experimental. 1994 ; Vol. 43, No. 3. pp. 378-384.
@article{998e30e4fa324ec6a20fe81769a62c16,
title = "Leucine kinetics during a brief fast in diabetes in pregnancy",
abstract = "The effect of diabetes in pregnancy on leucine turnover and oxidation was examined in 12 insulin-dependent diabetic (IDDM) subjects and 12 gestationally diabetic (GDM) subjects during the third trimester of pregnancy. The data were compared with those in normal pregnant women studied during the same time period and reported previously. Eight of the IDDM subjects were on continuous subcutaneous insulin infusion (insulin pump), and four were on conventional twice-daily insulin treatment. Of the GDM group, seven were on insulin therapy and five were on dietary management. Leucine kinetics were quantified using [1-13C]leucine tracer in combination with respiratory calorimetry and measurement of lean body mass using the H2[18O] dilution method. In addition, glucose kinetics were measured in insulin-treated subjects using [6,62H2]glucose tracer. Despite rigorous metabolic control, fasting plasma glucose (IDDM 5.5 ± 1.9 mmol/L [P <.05], GDM 4.7 ± 1.3 [P <.01], controls 3.6 ± .6, mean ± SD) and hemoglobin A1 ([HbA1] IDDM 7.9 ± 1.9{\%}, GDM 7.5{\%} ± 2.1{\%}) levels were higher in diabetic subjects. Although total insulin levels were higher in insulin-treated diabetic subjects, free-insulin concentrations were similar in all groups. Rates of excretion of urinary urea nitrogen and respiratory quotients were also similar. The rate of glucose turnover was lower in insulin-treated subjects compared with normals. Leucine flux, a measure of the rate of protein breakdown, and leucine oxidation were higher in IDDM and insulin-treated GDM subjects. The rate of leucine oxidation was increased in conventionally managed IDDM and insulin-treated GDM subjects. The increased rate of protein breakdown suggests an increased entry of amino acids into the metabolic pool, which in combination with the normal urea excretion rate, ie, the normal rate of amino acid/protein oxidation, may result in increased availability of amino acids for transplacental flux. Thus, rigorous management of IDDM in pregnancy and of insulin-treated GDM does not normalize whole-body protein breakdown, and may provide an explanation for the persistent fetal morbidity in diabetes in pregnancy.",
author = "Kalhan, {Satish C.} and Scott Denne and Patel, {Deepak M.} and Nuamah, {Isaac F.} and Savin, {Samuel M.}",
year = "1994",
doi = "10.1016/0026-0495(94)90108-2",
language = "English (US)",
volume = "43",
pages = "378--384",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Leucine kinetics during a brief fast in diabetes in pregnancy

AU - Kalhan, Satish C.

AU - Denne, Scott

AU - Patel, Deepak M.

AU - Nuamah, Isaac F.

AU - Savin, Samuel M.

PY - 1994

Y1 - 1994

N2 - The effect of diabetes in pregnancy on leucine turnover and oxidation was examined in 12 insulin-dependent diabetic (IDDM) subjects and 12 gestationally diabetic (GDM) subjects during the third trimester of pregnancy. The data were compared with those in normal pregnant women studied during the same time period and reported previously. Eight of the IDDM subjects were on continuous subcutaneous insulin infusion (insulin pump), and four were on conventional twice-daily insulin treatment. Of the GDM group, seven were on insulin therapy and five were on dietary management. Leucine kinetics were quantified using [1-13C]leucine tracer in combination with respiratory calorimetry and measurement of lean body mass using the H2[18O] dilution method. In addition, glucose kinetics were measured in insulin-treated subjects using [6,62H2]glucose tracer. Despite rigorous metabolic control, fasting plasma glucose (IDDM 5.5 ± 1.9 mmol/L [P <.05], GDM 4.7 ± 1.3 [P <.01], controls 3.6 ± .6, mean ± SD) and hemoglobin A1 ([HbA1] IDDM 7.9 ± 1.9%, GDM 7.5% ± 2.1%) levels were higher in diabetic subjects. Although total insulin levels were higher in insulin-treated diabetic subjects, free-insulin concentrations were similar in all groups. Rates of excretion of urinary urea nitrogen and respiratory quotients were also similar. The rate of glucose turnover was lower in insulin-treated subjects compared with normals. Leucine flux, a measure of the rate of protein breakdown, and leucine oxidation were higher in IDDM and insulin-treated GDM subjects. The rate of leucine oxidation was increased in conventionally managed IDDM and insulin-treated GDM subjects. The increased rate of protein breakdown suggests an increased entry of amino acids into the metabolic pool, which in combination with the normal urea excretion rate, ie, the normal rate of amino acid/protein oxidation, may result in increased availability of amino acids for transplacental flux. Thus, rigorous management of IDDM in pregnancy and of insulin-treated GDM does not normalize whole-body protein breakdown, and may provide an explanation for the persistent fetal morbidity in diabetes in pregnancy.

AB - The effect of diabetes in pregnancy on leucine turnover and oxidation was examined in 12 insulin-dependent diabetic (IDDM) subjects and 12 gestationally diabetic (GDM) subjects during the third trimester of pregnancy. The data were compared with those in normal pregnant women studied during the same time period and reported previously. Eight of the IDDM subjects were on continuous subcutaneous insulin infusion (insulin pump), and four were on conventional twice-daily insulin treatment. Of the GDM group, seven were on insulin therapy and five were on dietary management. Leucine kinetics were quantified using [1-13C]leucine tracer in combination with respiratory calorimetry and measurement of lean body mass using the H2[18O] dilution method. In addition, glucose kinetics were measured in insulin-treated subjects using [6,62H2]glucose tracer. Despite rigorous metabolic control, fasting plasma glucose (IDDM 5.5 ± 1.9 mmol/L [P <.05], GDM 4.7 ± 1.3 [P <.01], controls 3.6 ± .6, mean ± SD) and hemoglobin A1 ([HbA1] IDDM 7.9 ± 1.9%, GDM 7.5% ± 2.1%) levels were higher in diabetic subjects. Although total insulin levels were higher in insulin-treated diabetic subjects, free-insulin concentrations were similar in all groups. Rates of excretion of urinary urea nitrogen and respiratory quotients were also similar. The rate of glucose turnover was lower in insulin-treated subjects compared with normals. Leucine flux, a measure of the rate of protein breakdown, and leucine oxidation were higher in IDDM and insulin-treated GDM subjects. The rate of leucine oxidation was increased in conventionally managed IDDM and insulin-treated GDM subjects. The increased rate of protein breakdown suggests an increased entry of amino acids into the metabolic pool, which in combination with the normal urea excretion rate, ie, the normal rate of amino acid/protein oxidation, may result in increased availability of amino acids for transplacental flux. Thus, rigorous management of IDDM in pregnancy and of insulin-treated GDM does not normalize whole-body protein breakdown, and may provide an explanation for the persistent fetal morbidity in diabetes in pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=0028344565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028344565&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(94)90108-2

DO - 10.1016/0026-0495(94)90108-2

M3 - Article

VL - 43

SP - 378

EP - 384

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 3

ER -